Common Stock and Stock Options |
6 Months Ended |
|---|---|
Jun. 30, 2026 | |
| Common Stock and Stock Options | |
| Common Stock and Stock Options | Note 5. Common Stock and Stock Options Stock based compensation cost for all stock awards is based on the grant date fair value and recognized over the required service (vesting) period. Employees received compensation of 10,852 aggregate shares of common stock of the Company during the three months ended June 30, 2025. There was no stock-based compensation for the three months ended June 30, 2026. The shares granted for the three months ended June 30, 2025 had an aggregate value of $47,206 and were recorded as non-cash stock compensation expense in the condensed financial statements for the three months ended June 30, 2025. Employees received compensation of 16,596 and 10,852 aggregate shares of common stock of the Company during the six months ended June 30, 2026 and 2025, respectively. The shares granted in the first six months of 2026 had an aggregate value of $87,129 compared to $47,206 for the same period in 2025. These amounts were recorded as non-cash stock compensation expense in the financial statements for the six months ended June 30, 2026 and 2025, respectively. Employee Stock Options There were no stock options remaining as of June 30, 2026 or December 31, 2025. |